Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder

Santiago Pardo, Gavin Giovannoni, Christopher Hawkes, Jeannette Lechner-Scott, Emmanuelle Waubant, Michael Levy

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)A1-A2
JournalMultiple Sclerosis and Related Disorders
Volume33
DOIs
StatePublished - Aug 2019

Keywords

  • Complement
  • Disease-modifying therapy
  • Eculizumab
  • NMO
  • NMOSD
  • Neuromyelitis optica spectrum disorder

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this